Navigation Links
New Data Confirms Significant Improvement of Disease Signs and,Symptoms in Patients with Rheumatoid Arthritis

Second Multinational Phase III Study Provides Further Evidence of the Significant Role of IL-6 Receptor Inhibition in the Treatment of Rheumatoid Arthritis

BASEL, Switzerland, June 6, 2007-Roche announced today that Toward (1), the second multinational phase III Actemra (tocilizumab) study, successfully reached its primary endpoint and showed that a greater proportion of patients treated with Actemra in combination with traditional disease modifying drugs (DMARDs) achieved a significant improvement in disease signs and symptoms at week 24, compared to the those treated with DMARDs alone. The patients' symptoms were measured using the standard ACR score (2) assessment method. The patients enrolled in the study had active, moderate to severe rheumatoid arthritis (RA) and had experienced an inadequate response to DMARDs.

"The TOWARD trial data further documents the efficacy and safety of Actemra and the value of its IL-6 receptor inhibition. We look forward to further results from this extensive multinational Phase III development programme," commented William Burns, CEO Division Roche Pharmaceuticals.

The TOWARD trial included approximately 40% of patients from the United States and data from this trial will be submitted for presentation at international scientific meetings later this year and in 2008. TOWARD is the second of a programme of five phase III clinical trials running on Actemra, with two other trials due to report later in 2007. In January 2007 Roche reported that OPTION (3), the first of the phase III trials outside Japan, had successfully met its primary endpoint in patients who had an inadequate response to methorexate.

About the TOWARD study The TOWARD (Tocilizumab in cOmbination With traditional DMARD therapy) study was an international study treating 1216 patients with moderate to severe RA. The study was conducted at 130 study sites in 18 countries, including the USA. In th
'"/>




Page: 1 2 3 4

Related medicine technology :

1. Biofrontera AG Announces Clinical Study Confirms Excellent Efficacy of BF-200 ALA In Actinic Keratosis
2. Publication Confirms that EpCAM, the Target for Two of Micromets Product Candidates, Is Overexpressed on Cancer Stem Cells of Certain Cancers
3. New Research Confirms the Benefit of Extended-Release Dipyridamole Plus ASA for Preventing Recurrent Stroke in Low- and High-Risk Patients
4. Positive Clinical Data on CC-10004 Confirms Potential as Novel Oral Approach to Treating Inflammatory Diseases
5. Independent Publication Confirms Growing Therapeutic Challenge of T315I Mutation in Patients with CML, Notes ChemGenex
6. Independent Publication Confirms Growing Therapeutic Challenge of T315I Mutation in Patients with CML, Notes ChemGenex
7. New Study Confirms Role for Pertussis Immunization of Entire Family in Reducing Infant Pertussis
8. Actemra (tocilizumab) Third Phase III Study Results Show Significant Improvement in Symptoms of Patients with Rheumatoid Arthritis
9. TMC125 Showed Significant Virologic Response at Week 24 in Treatment-Experienced HIV Patients With NNRTI Resistance in Phase 3 Trials
10. Late Breaking Data Released at ADA Showed that the Investigational Use of Januvia and Metformin as Initial Combination Therapy Provided Significant Glucose Lowering Efficacy over 54 Weeks in Patients with Type 2 Diabetes
11. DiObex Presents Phase 2a Data of DIO-902 Demonstrating Trends of Improved Glycemic Control and Significant Reductions of LDL-Cholesterol and C-Reactive Protein
Post Your Comments:
(Date:9/19/2014)... and ORLANDO, Fla. , Sept. ... Inspire therapy continues to grow, with the publication of ... on-line in Otolaryngology – Head and Neck ... a worsening of both objective and subjective measures of ... attribute Inspire therapy for the reduction in obstructive sleep ...
(Date:9/19/2014)... Tenn. , Sept. 19, 2014  Over 200 ... the Future to Benefit the Radiation Oncology Institute (ROI), ... held at Golden Gate Park in San Francisco.  ... Dan Moore , CEO of Radiation Business Solutions, ... we have raised over $70,000 for the ROI this ...
(Date:9/19/2014)... , Sept. 19, 2014  CytRx Corporation (Nasdaq: ... specializing in oncology, today announced that David J. ... BioCentury,s 2014 NewsMakers in the Biotech Industry Conference on Friday, ... The conference will take place at the Millennium Broadway ... A live and archived webcast of the ...
Breaking Medicine Technology:New Data shows Reductions in obstructive sleep apnea (OSA) severity and improvement of quality of life with Inspire therapy 2New Data shows Reductions in obstructive sleep apnea (OSA) severity and improvement of quality of life with Inspire therapy 3New Data shows Reductions in obstructive sleep apnea (OSA) severity and improvement of quality of life with Inspire therapy 4Fifth Annual 5K Run for the Future to Benefit the Radiation Oncology Institute Breaks Attendance, Donation Records 2Fifth Annual 5K Run for the Future to Benefit the Radiation Oncology Institute Breaks Attendance, Donation Records 3CytRx to Present at BioCentury's 2014 NewsMakers in the Biotech Industry Conference 2CytRx to Present at BioCentury's 2014 NewsMakers in the Biotech Industry Conference 3
... Auxilium Pharmaceuticals, Inc. (Nasdaq: AUXL ) ... Stifel Nicolaus 2011 Healthcare Conference during September 7-9, 2011 ... Fickenscher, Chief Financial Officer, is scheduled to present an ... 11:30 am ET on Wednesday, September 7, 2011.   ...
... concept of smaller, thinner laparoscopic tools has been an ... advent of laparoscopic surgery. Some prominent manufacturers of surgical ... they did not perform to the standard that bariatric ... extremely thin instruments would bend under the stress of ...
Cached Medicine Technology:Auxilium Pharmaceuticals to Present at the Stifel Nicolaus 2011 Healthcare Conference 2Auxilium Pharmaceuticals to Present at the Stifel Nicolaus 2011 Healthcare Conference 3New Micro Laparoscopic Instruments for the Bariatric Surgery Allow for Less Scarring and Pain than Ever Before Possible 2
(Date:9/19/2014)... Sept. 19, 2014 (HealthDay News) -- Your brain structure could ... a new study suggests. Researchers at Yale University found ... known as the parietal cortex may be more likely to ... this area. , , The study, funded by the U.S. ... men and women living in the Northeast. The researchers sought ...
(Date:9/19/2014)... HealthDay Reporter THURSDAY, ... by stress and family conflicts before surgery may face ... new study suggests. Investigators found that patients with ... three times greater risk for complications compared to those ... "We,ve long known that patient quality of life is ...
(Date:9/19/2014)... treat and cure disease is a hugely promising ... the inability of doctors and scientists to effectively track ... patients without resorting to invasive procedures, like tissue sampling. ... online journal Magnetic Resonance in Medicine , researchers ... Medicine, University of Pittsburgh and elsewhere describe the first ...
(Date:9/19/2014)... --- Domestic violence occurs at least as frequently, ... compared to opposite-sex couples, according to a review ... , Previous studies, when analyzed together, indicate that ... of lesbian, gay and bisexual individuals. However, a ... paints an incomplete picture of the true landscape, ...
(Date:9/19/2014)... As summer vacations end and everyone returns ... now reminds area patients about the reality and impact of ... affected by gum disease, there is simply not an option ... years Dr. Krishnan has treated patients with varying degrees of ... that come in due to common symptoms such as bleeding ...
Breaking Medicine News(10 mins):Health News:Brain Structure Might Help Predict Risky Behavior 2Health News:Family Squabbles Can Derail Recovery From Cancer Surgery 2Health News:Family Squabbles Can Derail Recovery From Cancer Surgery 3Health News:A better way to track emerging cell therapies using MRIs 2Health News:Domestic violence likely more frequent for same-sex couples 2Health News:New York Periodontist Dr. Prabha Krishnan Now Raises Awareness about the Dangers of Untreated Decay, Gingivitis and Gum Disease During Self-Awareness Month 2Health News:New York Periodontist Dr. Prabha Krishnan Now Raises Awareness about the Dangers of Untreated Decay, Gingivitis and Gum Disease During Self-Awareness Month 3
... data browser developed by the University of California, Santa ... Diseases (GSID) will give researchers access to a wealth ... vaccine. Although the vaccine did not succeed in preventing ... valuable data for researchers studying how the virus evolves ...
... (NIH) has awarded one of 14 Clinical and Translational ... at Boston University Medical (BUMC) and Charles River Campuses ... 12 CTSAs awarded in 2007, and 12 awarded in ... build a national consortium of select centers that will ...
... PHILADELPHIA, May 29 It was around 8 PM on,the ... Pena Jr.,was found by his partner in his Ford F-250 ... a rollover. Pena has no memory of that night and ... -- a phenomenon that has his,doctors puzzled., (Photo: ...
... education and training, and program support ... MUNDELEIN, Ill., May 29 Knowing that pressure ... Industries,Inc. today introduced its Pressure Ulcer Prevention Program ... incontinence-associated skin,conditions, which may include dermatitis and skin ...
... by Breaking Through Barriers, NEWPORT NEWS, Va., ... Advocate Foundation today announced a strategic,collaboration that will ... access to timely information and specialized patient assistance,resources. ... of cancer,patients nationwide who are facing access to ...
... GenVault Corporation, the,leader in dry-state, room temperature biosample ... Now part of GE Healthcare, will,become a non-exclusive ... America., The GenSolve DNA recovery kit enables ... their archived samples with a simple, user-friendly,and reliable ...
Cached Medicine News:Health News:New HIV browser gives researchers access to valuable data from vaccine trials 2Health News:New HIV browser gives researchers access to valuable data from vaccine trials 3Health News:New HIV browser gives researchers access to valuable data from vaccine trials 4Health News:BUMC, BMC receives Clinical and Translational Science Award from NIH 2Health News:Protecting Those Who Protect America... Border Patrol Agent Luis Pena Now Quadriplegic From 'Roof Crush' in Rollover 2Health News:Medline's Pressure Ulcer Prevention Program Addresses New CMS Deadline of October 1, 2008 2Health News:Medline's Pressure Ulcer Prevention Program Addresses New CMS Deadline of October 1, 2008 3Health News:American Cancer Society, Patient Advocate Foundation Announce Free, Personalized Assistance for Cancer Patients 2Health News:American Cancer Society, Patient Advocate Foundation Announce Free, Personalized Assistance for Cancer Patients 3Health News:Whatman, Now Part of GE Healthcare, to Distribute GenVault DNA Recovery Kits in North America 2Health News:Whatman, Now Part of GE Healthcare, to Distribute GenVault DNA Recovery Kits in North America 3
... features including aspiration holes and additional ... procedures requiring precise dissection with decreased ... suction demands. ,Flexible design options ... nonretractable electrodes and multiple tip designs. ...
SOLOS Endoscopy shares your commitment to provide every patient with the highest quality care available through our ongoing research and development of advanced surgical instruments and diagnostic so...
SOLOS Endoscopy shares your commitment to provide every patient with the highest quality care available through our ongoing research and development of advanced surgical instruments and diagnostic so...
... Instruments incorporate a layered design unique in ... monitored to prevent stray electrosurgical burns along ... insulation failure or capacitive coupling; a well-documented ... into all AEM Instruments provides a neutral ...
Medicine Products: